Benitec Biopharma (NASDAQ:BNTC) Director Purchases $220,551.60 in Stock
Suvretta Capital Management acquired over 180,000 shares in late December, signaling increased institutional confidence with director ownership up 0.52%.
3 Articles
3 Articles
Benitec Biopharma (NASDAQ:BNTC) Director Suvretta Capital Management, L Acquires 50,000 Shares
Benitec Biopharma Limited (NASDAQ:BNTC – Get Free Report) Director Suvretta Capital Management, L purchased 50,000 shares of Benitec Biopharma stock in a transaction that occurred on Tuesday, December 23rd. The shares were purchased at an average cost of $12.85 per share, with a total value of $642,500.00. Following the transaction, the director directly owned 9,620,075 shares of the company’s stock, valued at $123,617,963.75. This represents a …
Benitec Biopharma (NASDAQ:BNTC) Director Purchases $220,551.60 in Stock
Benitec Biopharma Limited (NASDAQ:BNTC - Get Free Report) Director Suvretta Capital Management, L purchased 16,836 shares of the business's stock in a transaction on Friday, December 26th. The shares were bought at an average cost of $13.10 per share, for a total transaction of $220,551.60. Following the completion of the transaction, the director directly owned 9,634,395 shares in the company, valued at $126,210,574.50. This trade represents a …
Benitec Biopharma (NASDAQ:BNTC) Director Buys $1,040,081.28 in Stock
Benitec Biopharma Limited (NASDAQ:BNTC – Get Free Report) Director Suvretta Capital Management, L purchased 77,387 shares of the company’s stock in a transaction on Monday, December 29th. The stock was bought at an average price of $13.44 per share, for a total transaction of $1,040,081.28. Following the completion of the purchase, the director directly owned […]
Coverage Details
Bias Distribution
- 100% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
